SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 81 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2014. The put-call ratio across all filers is 2.65 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $51,000 | -26.1% | 29,511 | -4.3% | 0.00% | -25.0% |
Q2 2015 | $69,000 | +4.5% | 30,842 | -9.4% | 0.00% | 0.0% |
Q1 2015 | $66,000 | +1.5% | 34,052 | +39.4% | 0.00% | 0.0% |
Q4 2014 | $65,000 | -33.7% | 24,422 | -25.0% | 0.00% | -42.9% |
Q3 2014 | $98,000 | -25.8% | 32,567 | +1.3% | 0.01% | -22.2% |
Q2 2014 | $132,000 | -3.6% | 32,164 | +1.5% | 0.01% | -10.0% |
Q1 2014 | $137,000 | -13.8% | 31,701 | +4.2% | 0.01% | -9.1% |
Q4 2013 | $159,000 | – | 30,416 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 21,704,847 | $5,209,000 | 7.19% |
CAXTON CORP | 67,000 | $16,000 | 0.02% |
McQueen, Ball & Associates Inc. | 102,742 | $25,000 | 0.02% |
TWO SIGMA SECURITIES, LLC | 36,056 | $9,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,398,330 | $336,000 | 0.01% |
WEDBUSH SECURITIES INC | 45,000 | $11,000 | 0.00% |
Roundview Capital LLC | 21,100 | $5,000 | 0.00% |
Renaissance Technologies | 2,332,995 | $560,000 | 0.00% |
PANAGORA ASSET MANAGEMENT INC | 618,599 | $148,000 | 0.00% |
Virtu KCG Holdings LLC | 107,071 | $26,000 | 0.00% |